Target intelligence / Profile preview

Transforming growth factor beta messenger RNA 3' untranslated region (TGF-β mRNA 3'UTR)

Target
TGF-β mRNA 3'UTR
Molecular classification
Nucleic acid, Messenger RNA (mRNA) regulatory region
01

Overview

The TGF-β mRNA 3'UTR is a critical regulatory region of the messenger RNA encoding Transforming Growth Factor beta isoforms (TGF-β1, TGF-β2, and TGF-β3). This region contains various cis-acting elements, such as AU-rich elements (AREs) and microRNA (miRNA) binding sites, which control the stability and translation efficiency of the mRNA. In many pathological conditions, including advanced cancers and fibrotic diseases, TGF-β is overexpressed, leading to immunosuppression, epithelial-mesenchymal transition (EMT), and excessive extracellular matrix deposition. Therapeutic strategies targeting the TGF-β mRNA, including antisense oligonucleotides (ASOs) like Trabedersen and ISTH0036, aim to downregulate TGF-β production at the genetic level. These agents bind to the mRNA (often targeting regulatory regions like the 3'UTR or coding sequences) to induce degradation or block translation, thereby reversing the pro-tumorigenic and pro-fibrotic effects of the cytokine.

Other names
TGF-beta 3'UTRTGFB1 3'UTRTGFB2 3'UTRTGFB3 3'UTRTransforming growth factor beta 1 messenger RNA 3' untranslated regionTransforming growth factor beta 2 messenger RNA 3' untranslated region
02

Mechanism of action

Antisense inhibition (RNase H-mediated degradation), Steric blocking of translation, Modulation of mRNA stability

03

Biological functions

Regulation of mRNA stabilityRegulation of translationPost-transcriptional gene regulationBinding site for microRNAsBinding site for RNA-binding proteins
04

Disease associations

CancerFibrosisGlaucomaNeurodegenerative diseaseCardiovascular diseaseInflammation
05

Safety considerations

Systemic immunosuppressionOff-target effectsDelivery challenges (e.g., blood-brain barrier)Potential for inflammatory response
06

Interacting drugs

Trabedersen (AP 12009)

4 more in the full profile.

07

Biomarkers

TGF-beta protein levelsTGF-beta mRNA levelsPhosphorylated SMAD2/3 (pSMAD2/3)

Beyond the preview

Go deeper on Transforming growth factor beta messenger RNA 3' untranslated region (TGF-β mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transforming growth factor beta messenger RNA 3' untranslated region (TGF-β mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call